Vaginal laser therapy for genitourinary syndrome of menopause – systematic review

•Genitourinary syndrome of menopause affects between 53.8% and 90% of postmenopausal women.•The efficacy and safety of laser therapy have not been yet established and international societies do not endorse its use.•Treatment with carbon dioxide laser seems to improve scores on the Visual Analogue Sc...

Full description

Saved in:

Bibliographic Details
Published in:	Maturitas Vol. 156; pp. 37 - 59
Main Authors:	Mension, Eduard, Alonso, Inmaculada, Tortajada, Marta, Matas, Isabel, Gómez, Sílvia, Ribera, Laura, Anglès, Sònia, Castelo-Branco, Camil
Format:	Journal Article
Language:	English
Published:	Ireland Elsevier B.V 01.02.2022
Subjects:	Atrophic vaginitis Atrophy - pathology Cross-Sectional Studies Female Genitourinary syndrome of menopause Humans Laser Therapy Lasers, Gas - therapeutic use Menopause Quality of Life Sexual dysfunction Vagina - pathology Vulvovaginal atrophy VVA FDA Sexual dysfunction ICIQ‐UI SF UDI-6 QoL UDIQ PFDI-20 KHQ VHI Atrophic vaginitis GSM Genitourinary syndrome of menopause SUI PGI-I SF-12 CIS NSR Vulvovaginal atrophy SPEQ ICIQ‐OAB FLUTS FSFI VMI NHLBI WHOQoL-BREF
ISSN:	0378-5122, 1873-4111, 1873-4111
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!